Why the study?
Do inflammatory cytokines (IL-6, IL-8, MCP-1) and NT-proBNP predict long-term risk of death or heart failure in patients with acute coronary syndrome?
Do inflammatory cytokines (IL-6, IL-8, MCP-1) and NT-proBNP predict long-term risk of death or heart failure in patients with acute coronary syndrome?
Elevated levels of IL-6, MCP-1, and NT-proBNP early after acute coronary syndrome independently predict the long-term risk of death or heart failure.
No takes yet. Share an insight, caveat, or question.
May refine post-ACS risk stratification beyond CRP and troponin; leaves open whether targeting these markers improves outcomes.
Kavsak et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: